Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.78 |
| ▸ | KCNJ1 | P48048 | 2/20 | 0.56 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 3/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL358325 | 0.94 | TSHR (0.75) | TSHRKCNJ1LOXL2KCNH2ALDH1A1 | |
| SCHEMBL10879042 | 0.92 | TSHR (0.72) | TSHRKCNJ1LOXL2KCNH2ALDH1A1 | |
| SCHEMBL9545598 | 0.92 | TSHR (0.72) | TSHRKCNJ1LOXL2KCNH2ALDH1A1 | |
| SCHEMBL6455031 | 0.92 | TSHR (0.72) | TSHRKCNJ1LOXL2KCNH2ALDH1A1 | |
| SCHEMBL250473 | 0.88 | TSHR (1.00) | TSHRKCNJ1LOXL2KCNH2ALDH1A1 | |
| SCHEMBL30758863 | 0.87 | TSHR (0.69) | TSHRKCNJ1LOXL2KCNH2ALDH1A1 | |
| SCHEMBL18913824 | 0.87 | TSHR (0.69) | TSHRKCNJ1LOXL2KCNH2ALDH1A1 | |
| SCHEMBL9385011 | 0.86 | TSHR (0.64) | TSHRKCNJ1LOXL2KCNH2ALDH1A1 | |
| SCHEMBL9317263 | 0.85 | TSHR (0.62) | TSHRKCNJ1KCNH2CA2CHRM2 | |
| Methyl Alcohol SCHEMBL5318262 | 0.84 | TSHR (0.92) | TSHRKCNJ1LOXL2KCNH2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119591793-A | Preparation method of halogen-free flame-retardant latex | 世慕安防科技(江苏)有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-118624324-A | Preparation and value setting method of high-purity paranitrotoluene standard substance | 西安近代化学研究所 | 2024-09-10 | — | — | CN | claimed |
| CN-103288751-B | A kind of preparation method of high-purity nifekalant hydrochloride | BAILI PHARMACEUTICAL CO., LTD., SICHUAN PROV. (CN) | 2016-04-20 | — | — | CN | claimed |
| CN-103288751-A | Preparation method of high-purity nifekalant hydrochloride | SICHUAN BIOKIN PHARMACEUTICAL CO LTD | 2013-09-11 | — | — | CN | claimed |
| US-20070093474-A1 | Methods of modulating neurotrophin-mediated activity | PAINCEPTOR PHARMA CORPORATION (CA) | 2007-04-26 | — | — | US | claimed |
| JP-3294260-A | — | — | None | — | — | JP | disclosed |
| CN-119591793-A | Preparation method of halogen-free flame-retardant latex | 世慕安防科技(江苏)有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-118955244-A | Method for preparing primary alcohol by homogeneously catalyzing and reducing carboxylic acid derivative by using N-heterocyclic carbene copper complex | 延安大学 | 2024-11-15 | — | — | CN | disclosed |
| CN-118624324-A | Preparation and value setting method of high-purity paranitrotoluene standard substance | 西安近代化学研究所 | 2024-09-10 | — | — | CN | disclosed |
| US-20240287076-A1 | COMPOUNDS FOR TARGETING DEGRADATION OF BRUTON'S TYROSINE KINASE | C4 THERAPEUTICS, INC. | 2024-08-29 | — | — | US | disclosed |
| CN-117089070-B | Liquid crystal aligning agent and application thereof | 波米科技有限公司 | 2024-04-16 | — | — | CN | disclosed |
| WO-2024067560-A1 | SULFONAMIDE COMPOUND AND MEDICAL USE THEREOF | 中国药科大学 | 2024-04-04 | — | — | WO | disclosed |
| EP-0162208-B1 | NOVEL N-SUBSTITUTED 3,4-DIHYDROPYRIMIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS | SUNTORY KABUSHIKI KAISHA, also known as SUNTORY LTD. (JP) | 1989-11-23 | — | — | EP | disclosed |
| US-4720581-A | ANTISEPTICS, PRESERVATIVES | SANOFI (FR) | 1988-01-19 | — | — | US | disclosed |
| US-4683234-A | HYPOTENSIVE AGENTS, ANTI-ANGINA | SUNTORY LIMITED (JP) | 1987-07-28 | — | — | US | disclosed |
| EP-0130025-B1 | 2-ALKYLTHIOPENEM DERIVATIVES | PFIZER INC. (US) | 1987-07-08 | — | — | EP | disclosed |
| CN-86102923-A | The method for preparing antibiotic derivatives | — | 1986-11-12 | — | — | CN | disclosed |
| US-4619924-A | BACTERICIDES | PFIZER INC. (US) | 1986-10-28 | — | — | US | disclosed |
| EP-0162208-A2 | Novel N-substituted 3,4-dihydropyrimidine derivatives, processes for preparing them and pharmaceutical compositions | SUNTORY KABUSHIKI KAISHA, also known as SUNTORY LTD. (JP) | 1985-11-27 | — | — | EP | disclosed |
| EP-0130025-A1 | 2-Alkylthiopenem derivatives | PFIZER INC. (US) | 1985-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240287076-A1 | COMPOUNDS FOR TARGETING DEGRADATION OF BRUTON'S TYROSINE KINASE | BTK, SYK, LYN | TSHR 3544/4885KCNJ1 4760/4885LOXL2 463/4885 |
| US-20070093474-A1 | Methods of modulating neurotrophin-mediated activity | NGF, BDNF, NTRK2 | TSHR 972/4885KCNJ1 4468/4885LOXL2 2438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.